Rat aorta rapid response to estrone and estradiol are mediated by different mechanisms;El estradiol y la estrona modulan la función vascular por mecanismos diferentes

Revista Argentina de Endocrinologia y Metabolismo

Volumn 40, Issue 1, 2003, Pages 3-12

  Massheimet, V ^a   Polini, N ^a   Benozzi, S ^a   Alvarez , C ^a   Selles J ^a  

^a UNIVERSIDAD NACIONAL DEL SUR   (Argentina)

Author keywords

Aortic tissue; Eicosanoids; Estrogen; Estrone; Nitric oxide

Indexed keywords

ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; ARGININE; CALCIUM CHELATING AGENT; CALCIUM ION; CITRULLINE; EGTAZIC ACID; ESTRADIOL; ESTRONE; ICOSANOID; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PROSTACYCLIN; PROSTAGLANDIN SYNTHASE INHIBITOR; THROMBOXANE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; DEVICE; DRUG EFFECT; EXTRACELLULAR CALCIUM; FEMALE; IN VITRO STUDY; ION EXCHANGE CHROMATOGRAPHY; NONHUMAN; PROSTAGLANDIN RELEASE; RAT; SIGNAL TRANSDUCTION; THIN LAYER CHROMATOGRAPHY; THROMBOCYTE AGGREGATION; THROMBOCYTE RICH PLASMA;

EID: 0038487160     PISSN: 03264610     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Moncada, S.; Pamer, R.; Higgs, E. Nitric oxide physiology, pathophysiology and pharmacology. Pharmacol. Res. 43: 109-142, 1991
2. Michel, T.; Li, G.; Busconi, C. Phosphorylation and subcellular translocation of endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA 90: 6252-6256, 1993
3. Knowles, R.; Moncada, S. Nitric oxide synthase in mammals. Biochem. J. 298: 249-258, 1994.
4. Oravee, S.; Demuth, K.; Myara, I. y col. The effect of high density lipoprotein subfractions on endothelial eicosanoid secretion Thrombosis Research 92: 65-71, 1998. White M., Zamudio.
5. Knopp, R.; Zhu, X.; Bonet, B. Effects of estrogens lipoprotein metabolism and cardiovascular disease in women. Atherosclerosis 110: 583-591, 1994.
6. Psaty, P.; Heckert, S.; Atkins, D. y col. The risk of myocardial infarction associated with the combined used of estrogen and progestins in post-menopausal women. Arch, Intern. Med. 154: 1333-1339, 1997.
7. Falkenstein, E.; Tillman, H.; Christ, M. y col. Multiple actions of steroid hormones, a focus on rapid non genomic effects. Pharmacol. Rev. 55: 513-556, 2000.
8. Mendelsohn, M.; Karas, R. The protective effects of the estrogen on the cardiovascular system. The New Eng.J. Med. 340: 1801-1811, 1999.
9. Hemssell, P.; Graden, J.; Brenner P. y col. Plasma precursors of estrogen II. Correlation of the extent of conversion of androstenedione to estrone with age. Clin. Endocrinol. Metab. 38: 476-479, 1974
10. Sellés, J.; Polini, N.; Alvarez, C. y col. "Progesterone and 17β-estradiol stimulate nitric oxide syntase activity in rat aorta and inhibit platelet aggregation" Life Scienes 69: 815-827, 2001.
11. Sellés, J.; Polini, N.; Alvarez, C. y col. Nongenomic action of progesterone in rat aorta: role of nitric oxide and prostaglandins. Cell. Signalling, 14(5): 431-436, 2002
12. Massheimer, V.; Polini, N.; Alvarez, C. y col. 17-beta estradiol rapid stimulation of rat aorta NOS activity is prevented by estrogen deficiency. Maturitas, The European Menopause Journal 43: 55-64, 2002.
13. Massheimer, V.; Mendiberri, J.; Alvarez, C. y col. La estimulación con estrona o progesterona de la óxido nítrico sintasa (NOS) de tejido aórtico de rata se modifica por deficiencia de hormonas ováricas. Revista Argentina de Endocrinologia y Metabolismo Vol. 38 N°1 pg 160, 2001
14. Gryglewski, R.J.; Palmer, R.M.J.; Moncada, S. Superoxide anion is involved in the breakdown of endothelium derived vascular relaxing factor. Nature 1986; 320: 454-456, 1986.
15. Kikuta, K.; Sawamura, T.; Miwa, S. y col. High-affinity arginine transport of bovine endothelial cells is impaired by lysophosphsatiddycholine Circ. Res. 83: 1088-1096, 1998.
16. Lowry, O.H.; Rosebrough, N.J.; Farr, A.L. y col. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951; 195: 265-277, 1951.
17. Hayashi, T.; Yamada, K.; Esaki, T. y col. Estrogen increases endothelial nitric oxide by a receptor mediated system. Biochem. Biophys. Res. Commun. 1995; 214: 847-855, 1995.
18. Salmon, J.; Flower, R. Extraction and Thin layer Chromatography of arachidonic acid metabolites. Methods in Enzymology, Academic Press 86: 477-493, 1982.
19. Chen, Z.; Yuhamma, I.; Calcheva-Gargova, P. y col. Estrogen receptor alpha mediates the non-genomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 103:401-406, 1999
20. Linton, M.E; Fazzio, S. Cyclooxigenase-2 and atherosclerosis. Curr Opin Lipidol 13: 497-504, 2002
21. Joswig, M.; Wunderle, V.; Ziegler, R. y col. Postmenopausal hormone replacement therapy and the vascular biology. Exp Clin. Endocrinol Diabetes 107: 477-487, 1999
22. Garg, U. and Hassid, A. Nitric oxide generation vasodilators and 8-bromo cyclic guanosine monophospate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83: 1774-1777, 1989
23. Kubes, P.; Suzuki, M.; Granger, D. Nitric oxide an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci, USA 88: 4651-4655, 1991.
24. Radomski, M.; Palmer, R.; Moncada, S. An L-arginine-nitric oxide pathway present in human platelets regulates aggregation Proc. Natl. Acad. Sci, USA 87: 5195-5197, 1990
25. von der Leyen, H.; Gibbons, G.; Morishita, R. y col. Gene therpapy inhibition neointimal vascular lesion in vivo transfer of endothelial cell nitric oxide synthase gene. Proc. Natl. Acad. Sci, USA 92: 1137-1141, 1995.
26. Haynes, W.; Webb, D. Endothelin as a regulator of cardiovascular function in health and disease. Journal of Hypertension 16: 1081-1098, 1998.
27. Seeger, H.; Mueck, A.O.; Lippert, T.H. "Effect of estradiol metabolites on prostacyclin synthesis in human endothelial cell cultures". Life Sciences 65:167-170, 1999.
28. Dogne, J.; Leval, X.; Delarge, J. y col. New trends in thromboxane and prostacyclin modulators. Curr. Med. Chem. 7: 609-628, 2000.